This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5jyy
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
==Structure-based Tetravalent Zanamivir with Potent Inhibitory Activity against Drug-resistant Influenza Viruses== | ==Structure-based Tetravalent Zanamivir with Potent Inhibitory Activity against Drug-resistant Influenza Viruses== | ||
| - | <StructureSection load='5jyy' size='340' side='right' caption='[[5jyy]], [[Resolution|resolution]] 2.10Å' scene=''> | + | <StructureSection load='5jyy' size='340' side='right'caption='[[5jyy]], [[Resolution|resolution]] 2.10Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[5jyy]] is a 1 chain structure. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=5e6l 5e6l]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5JYY OCA]. For a <b>guided tour on the structure components</b> use [ | + | <table><tr><td colspan='2'>[[5jyy]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Influenza_A_virus Influenza A virus]. This structure supersedes the now removed PDB entry [http://oca.weizmann.ac.il/oca-bin/send-pdb?obs=1&id=5e6l 5e6l]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5JYY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5JYY FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=6PY:5-(ACETYLAMINO)-2,6-ANHYDRO-4-CARBAMIMIDAMIDO-3,4,5-TRIDEOXY-7-O-[(2-METHOXYETHYL)CARBAMOYL]-D-GLYCERO-D-GALACTO-NON-2-ENONIC+ACID'>6PY</scene>, <scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.1Å</td></tr> |
| - | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=6PY:5-(ACETYLAMINO)-2,6-ANHYDRO-4-CARBAMIMIDAMIDO-3,4,5-TRIDEOXY-7-O-[(2-METHOXYETHYL)CARBAMOYL]-D-GLYCERO-D-GALACTO-NON-2-ENONIC+ACID'>6PY</scene>, <scene name='pdbligand=BMA:BETA-D-MANNOSE'>BMA</scene>, <scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr> | |
| - | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5jyy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5jyy OCA], [https://pdbe.org/5jyy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5jyy RCSB], [https://www.ebi.ac.uk/pdbsum/5jyy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5jyy ProSAT]</span></td></tr> | |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/R4NFR6_9INFA R4NFR6_9INFA] Catalyzes the removal of terminal sialic acid residues from viral and cellular glycoconjugates.[RuleBase:RU361252] |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 20: | Line 19: | ||
</div> | </div> | ||
<div class="pdbe-citations 5jyy" style="background-color:#fffaf0;"></div> | <div class="pdbe-citations 5jyy" style="background-color:#fffaf0;"></div> | ||
| + | |||
| + | ==See Also== | ||
| + | *[[Neuraminidase 3D structures|Neuraminidase 3D structures]] | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Influenza A virus]] |
| - | [[Category: Bi | + | [[Category: Large Structures]] |
| - | [[Category: Fu | + | [[Category: Bi Y]] |
| - | [[Category: Gao | + | [[Category: Fu L]] |
| - | [[Category: Li | + | [[Category: Gao GF]] |
| - | [[Category: Li | + | [[Category: Li X]] |
| - | [[Category: Lu | + | [[Category: Li Y]] |
| - | [[Category: Lv | + | [[Category: Lu X]] |
| - | [[Category: Qi | + | [[Category: Lv X]] |
| - | [[Category: Wu | + | [[Category: Qi J]] |
| - | [[Category: Yan | + | [[Category: Wu Y]] |
| - | [[Category: Zhang | + | [[Category: Yan J]] |
| - | + | [[Category: Zhang S]] | |
| - | + | ||
| - | + | ||
Current revision
Structure-based Tetravalent Zanamivir with Potent Inhibitory Activity against Drug-resistant Influenza Viruses
| |||||||||||
Categories: Influenza A virus | Large Structures | Bi Y | Fu L | Gao GF | Li X | Li Y | Lu X | Lv X | Qi J | Wu Y | Yan J | Zhang S
